Empirical and rational approaches for development of inhibitors of the human immunodeficiency virus — HIV-1
Open Access
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 60 (2), 315-329
- https://doi.org/10.1016/0163-7258(93)90013-4
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Peptide aldehydes as inhibitors of HIV proteaseFEBS Letters, 1993
- Structural studies of the anti-HIV agent 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T)Biochemical and Biophysical Research Communications, 1991
- Comparative Studies of 2′,3′‐Didehydro‐2′,3′‐Dideoxythymidine (D4T) with other Pyrimidine Nucleoside AnaloguesAnnals of the New York Academy of Sciences, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Anti-retroviral therapy of AIDS and related disorders: General principles and specific development of dideoxynucleosidesPharmacology & Therapeutics, 1989
- Peptide substrates and inhibitors of the HIV-1 proteaseBiochemical and Biophysical Research Communications, 1989
- Properties of 2′,3′-dideoxy-2′,3′-dehydrothymidine 5′-triphosphate in terminating DNA synthesis catalyzed by several different DNA polymerasesFEBS Letters, 1987
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- n‐Alkylboronic acids as bifunctional reversible inhibitors of α‐chymotrypsinFEBS Letters, 1970
- Synthesis and biological activities of iododeoxyuridine, an analog of thymidineBiochimica et Biophysica Acta, 1959